MENU

MNPR Monopar Therapeutics Inc Forecast, Technical & Fundamental Analysis

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology... Show more

MNPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
MNPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in building a drug development pipeline of oncology therapeutics in late preclinical and clinical development stages

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1000 Skokie Boulevard
Phone
+1 847 388-0349
Employees
22
Web
https://www.monopartx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ALVIX11.130.11
+1.03%
American Century Focused Lg Cap Val Inv
SPXKX90.22N/A
N/A
Shelton S&P 500 Index K
MSDVX22.39N/A
N/A
BlackRock Equity Dividend Svc
WFEMX22.45N/A
N/A
WCM Focused Emerging Markets Investor
VEILX15.99N/A
N/A
VELA International A

MNPR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with QNCX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-0.41%
QNCX - MNPR
36%
Loosely correlated
-1.23%
GMAB - MNPR
35%
Loosely correlated
+1.23%
ROIV - MNPR
32%
Poorly correlated
+1.95%
PTCT - MNPR
32%
Poorly correlated
+4.08%
IMVT - MNPR
32%
Poorly correlated
+2.63%
More
Monopar Therapeutics (MNPR) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com